Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma

This study has been completed.
Information provided by (Responsible Party):
Genentech, Inc. Identifier:
First received: April 15, 2004
Last updated: May 14, 2014
Last verified: May 2014